These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8856283)

  • 21. [Disorders of lipid metabolism in patients with chronic renal failure and after kidney transplantation].
    Klin M
    Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):667-70. PubMed ID: 1492031
    [No Abstract]   [Full Text] [Related]  

  • 22. Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
    Kimak E; Solski J; Janicka L; Ksaziek A; Janicki K
    Clin Chem Lab Med; 2000 May; 38(5):421-5. PubMed ID: 10952225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid and apolipoproteins (ApoAI, ApoB, Apo CIII, ApoE) disturbance in hemodialysis (HD) and renal transplant (Tx) patients.
    Janicki K; Solski J; Janicka L; Kimak E; Bednarek-Skublewska A; Stettner S; Molas G
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):459-66. PubMed ID: 16146031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic kidney disease: the silent enemy?
    Sladen RN
    Anesth Analg; 2011 Jun; 112(6):1277-9. PubMed ID: 21613197
    [No Abstract]   [Full Text] [Related]  

  • 25. Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins.
    Atger V; Beyne P; Frommherz K; Roullet JB; Drüeke T
    Ann Biol Clin (Paris); 1989; 47(8):497-501. PubMed ID: 2690681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lipoprotein(a) and lipids in chronic renal insufficiency and kidney transplant].
    Ochoa-Sosa CA; Mondragón-Rodríguez G; Zamora-González J; Cardoso-Saldaña G; Herrera-Acosta J; Posadas-Romero C
    Rev Invest Clin; 1998; 50(4):301-6. PubMed ID: 9830317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Causes of coronary heart disease in patients on renal replacement therapy.
    Wanner C; Zimmermann J
    Kidney Blood Press Res; 1998; 21(2-4):287-9. PubMed ID: 9762860
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum lipoproteins in renal transplant patients: the effect of cyclosporine on lipoprotein(a).
    Süleymanlar G; Ozben T; Sapan M; Yìlmaz H; Yakupoglu G; Karpuzoglu T
    Transplant Proc; 1994 Oct; 26(5):2637-8. PubMed ID: 7940822
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chronic kidney failure].
    Laville M
    Rev Prat; 2001 Oct; 51(16):1833-40. PubMed ID: 11795131
    [No Abstract]   [Full Text] [Related]  

  • 30. [Isolation and immunologic determination of apolipoprotein C-II and C-III in human serum].
    Gehrisch S; Jaross W
    Z Med Lab Diagn; 1985; 26(3):157-65. PubMed ID: 4024691
    [No Abstract]   [Full Text] [Related]  

  • 31. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
    Sechi LA; Zingaro L; Catena C; Perin A; De Marchi S; Bartoli E
    Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum lipoprotein (a) levels in maintenance hemodialysis patients.
    Okura Y; Saku K; Hirata K; Zhang B; Liu R; Ogahara S; Naito S; Kajiyama G; Arakawa K
    Nephron; 1993; 65(1):46-50. PubMed ID: 8413789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ghrelin and other appetite-regulating hormones in paediatric patients with chronic renal failure during dialysis and following kidney transplantation.
    Arbeiter AK; Büscher R; Petersenn S; Hauffa BP; Mann K; Hoyer PF
    Nephrol Dial Transplant; 2009 Feb; 24(2):643-6. PubMed ID: 18809976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of lipoprotein (a) after renal transplantation: short-term follow-up.
    Yang CW; Kim YS; Kim SY; Chang YS; Yoon YS; Bang BK
    Nephron; 1994; 67(3):364. PubMed ID: 7936033
    [No Abstract]   [Full Text] [Related]  

  • 35. Coming back to dialysis after kidney transplant failure.
    Messa P; Ponticelli C; Berardinelli L
    Nephrol Dial Transplant; 2008 Sep; 23(9):2738-42. PubMed ID: 18524788
    [No Abstract]   [Full Text] [Related]  

  • 36. Preserving residual renal function in dialysis: what we know.
    Patel N; Hu SL
    Semin Dial; 2015; 28(3):250-8. PubMed ID: 25231758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Residual renal function in patients on peritoneal dialysis: effect of peritonitis episodes.
    Rivera-Gorrin M; Teruel-Briones JL; Rodríguez-Mendiola N; Díaz-Domínguez M; Ruiz-Roso G; Quereda-Rodríguez-Navarro C
    Nefrologia; 2014 Nov; 34(6):802-4. PubMed ID: 25415582
    [No Abstract]   [Full Text] [Related]  

  • 38. Competitive enzyme immunoassay for human serum apolipoproteins C1, C11, and C111.
    Fu MD; Liu BW; Liu WZ; Fang DZ
    Clin Chim Acta; 1987 Aug; 167(3):339-40. PubMed ID: 3304723
    [No Abstract]   [Full Text] [Related]  

  • 39. Lipoprotein(a) levels in hemodialysis patients: relation to glucose intolerance and hemodialysis duration.
    Fiorini F; Masturzo P; Mij M; Bertolini S
    Nephron; 1995; 70(4):500-1. PubMed ID: 7477660
    [No Abstract]   [Full Text] [Related]  

  • 40. [Malondialdehyde concentration in the serum of children with chronic renal failure, chronic hemodialysis and kidney transplantation].
    Otting U; Hellmann C
    Z Urol Nephrol; 1990 Mar; 83(3):141-8. PubMed ID: 2356668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.